KK
LAB icon

KLP Kapitalforvaltning’s Standard BioTools LAB Stock Holding History

KLP Kapitalforvaltning’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-53,066
Closed -$48.8K – 2179
2026
Q1 		$48.8K Hold
53,066
– – ﹤0.01% 2138
2025
Q4 		$67.9K Buy
53,066
+12,900
+32% +$17.3K ﹤0.01% 2128
2025
Q3 		$52.2K Hold
40,166
– – ﹤0.01% 2148
2025
Q2 		$48.2K Hold
40,166
– – ﹤0.01% 2159
2025
Q1 		$43.4K Hold
40,166
– – ﹤0.01% 2204
2024
Q4 		$70.3K Buy
+40,166
New +$74.8K ﹤0.01% 2191

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

KLP Kapitalforvaltning's LAB Position: Q2 2026 in Review

KLP Kapitalforvaltning sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 53,066 shares — an estimated $48.8K sold.

KLP Kapitalforvaltning first reported a position in LAB in Q4 2024 and held it in 6 quarters. The position peaked at $70.3K in Q4 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • KLP Kapitalforvaltning reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 53,066 Standard BioTools shares in Q2 2026, an estimated $48.8K.
  • KLP Kapitalforvaltning first reported a position in Standard BioTools in Q4 2024 and held it in 6 quarters.
  • KLP Kapitalforvaltning's Standard BioTools position peaked at $70.3K in Q4 2024.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.